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Obje&es. TLC %dy evalo~t(5 the inctdence of reslenmis 
after surcessful diroettonal coronary atberwtomy and identi8es 
risk facton far r&enosis. 
Sackground. Directional coronary sthcrectomy has been 
shown to be a safe aad effective treatment of obstmctivc oronary 
artery disnse; however, tnfwmntioa regarding restenoris lime 
bed. 
M&&b. Between Cktober ,986 and December 1989. 289 
palienS witk 332 l&as were successfally treated with directional 
mronrry slberectemy and folkwd up pmspwtivety. Clinical 
foltawup iafermatioa was available for 98% and sngiographic 
fDlkwua itiammlion was &ained for 82% a! aa~rwimately 6 
site of interventioa. 
RtsouS. Seventy-four perwnt of patients were either asyrafdo. 
matic er ctinkally impmwl after the pmc&tre. Thtrty.two 
percent were subwquently treated by coronary artery bypPy 
surgery (14%). pprcutaaeam transbmiiual caromwy al@Jpt&y 
(4%) or w-et atbewctany (13%). Angt~pkic evidener sf 
restrnmir was obscned in 42%. The r&en&~ rate in native 
mronoryarte~~wp93I%fwpri~laionraod28~aaml49%, 
respwtiwty, (Or llsiws trxated with we or twe previaia angia 
pfasty prcwboer. The restmosb We fw slpbc,z.,w vein grafts 
was 53% for pimary lat.ms and 58% a5d 82%, reipecti”rty, for 
lesbms treated witb oa or two prevtws wgtop& pracedurep. 
Tlte median interval to an&mpbkaUy documented r&em& 
was 133 days. A b&r restenasis rate vms aswziated with a 
saphonaur vein gmtl, bypartercrbm, a longer Won (210 mm). a 
smatter Vessel diier I<3 P. .,, a tmiKakw ksbm aad nse Of 
a smatter (68) d&.x. 
Conclusions. RMelu& rem&E a liitatioa ef .xredtanat 
mronary stbetwtamy. A SOW d ptierds with kwger vessels. 
shorter lpsions or k&xts treated wfth a kuger (‘IF device may 
have a “we favorabk e,Wame. 
Despite improvement in technical skills and equipment, 
restenosis after initial successful prcutaneous transluminal 
coronary aogioplasty remains a- major limitation of this 
widely used orocedurc (t-4). Recent studies (5-8) have 
suggested thai restenosis rates atIer successful angioplasty 
ax bigixr than originally reponed. with restenosis occurring 
in approximately 40% of lesions within 6 months. Restenosis 
is usuallv caused hv smooth muscle ce!l prolifemtion at the 
intetven~ion site aa a response to the v&ular injury pro- 
duced bv balloon dilations (3.9-12). In addition to cell 
proliieraiion, elastic recoil may contribute to restenosis in 
some casea (13). 
Many new interventional techniques uch as atherec- 
tomy, laser ablation or stenting have been developed to 
overcome same of the limitations of angioplasty including 
restenosis. Directional coronay atherectomy is a new trans- 
luminal procedure for the treatment of coronary arteries by 
remwing obstructive tissue by excision rather !han dilation 
of the lesion by a balloon (14,lS). Tbis procedure was show* 
to be effective and safe in selected cases and the atherec- 
tomy device was approved by the Food and Drug Adminis- 
tration (16). Beca& it is a new procedure, only limited 
information is available regarding restenosis (17-21). 
It was hypothesized that debulking of obstructive tissue 
by directional coronary atherectomy may reduce restenosis 
by I) producing a large postiaterventional lumen. 2) creating 
a smooth surface at the intervention site, aad 3) preventing 
elastic recoil. 
The PUIDOS~ of this study was to evaluate the incidence of 
rest&is after successful birectional coronary atherectamy 
of both native coronary arteries aad saphenous vein srafts 
and to identify factors associated with restenosis. 
Methods 
The protocol for use of the directional coronary atherec- 
tamy ca;heter (Simpson Coronary AtberoCath. Devices for 
Vascular Interwntion, Inc.) was reviewed aad approved by
the Institutional Review Board at Sequoia Hospital. Before 
the procedure, each patient was iaformed about the nature of 
the pmcedure and written consent was obtained. 
Atherectomg procedure. Details uf patient selection and the two best orthogonal projections were selected. After 
the atherectomy proccdv~ xc described in detail elsewhere atherectomy, repeat angiograms were obtained in the 
(16). In brief, the general guidelines for patient selection same views. For the follow-up cardiac catheteriizcion, 
included patients with lesions in native coronary ~n&s cineangiograms were obtained in multiple projections, in- 
or ~~pke~ous vein grafts and pr!zi!t?.l or middle segments cluding the two best orthogonal views used during the initial 
of nonto~:uous nondiffusely diseased or not significantly atherectomv nrocedure. Aneiaarams were suantitativelv 
calcified vessels 22.5.mm diamctcr. The procedure was measured by iwo experienceh interventional cardiolagist~ 
xrformed ~ercutaneouslv throuch an I I or Y.:F cuidinr 
catheter (t&es for V~scular~lntervention. 1nc.i using 
(T.H.. M.H.R.), using electronic calioen. Analyses of fol- 
low-up angiograms w&e performed without knowledge of 
a .,. 6 or 7F Simpson iorunarv AtbcroCath. After cannula- the patients chmcat data. However, to identify the treated 
tton of the coronary artery with a guiding catheter, a segment before quantitative measurement, experienced an- 
0.014.in. (0.036-cm) Hi-Torque floppy wire (Advanced giographers compared cineaogiograms perGoormed before 
Cardiovascular Systems) was advanced across IhP !ezion. atherectomy aid at follow-up. Lesion lengths before 
The Simpsoo Coronary AtheroCath was ther advanced OVC~ atherectomy were measured in the view in which they 
the suide wire to the lesion nnd appmpriately positioned. 
Mul$le CUIS (generally to to 151 w&e p&for&using 5. to 
appearea to he the longest (io general. the tight anterior 
oblique riew for the leti anterior descending anmy, the left 
?O.psi ba!!nan inflation pressure with various orientations of anterior oblique view for the right coronary artery and the 
the window. The catheter was then withdrawn into the right or left anterior oblique view for the saphenous vein 
guiding catheter and the atherectomy site was evaluated w’ 
angiogiaphy. If signiftcant stenosis remained, subsequcn 
graft or left circumflex artery). The view with the most 
aienificant stenosis was used to measure the areatherectomv 
ntherecromv was oerformed bv “sine tither a higher inflation st&osis as well as the postatherectomy arti follow-up St;- 
Pressure of the bstloon (30 to 40 psi1 or a larger QIWICG,ILIII) XliL. T!!? .15-~:-!~-&;;.x,W, UI foe stenosis. me-Zsstii 
device ir ppropriate. If the atherectamy catheter could not diameter in a normal segment and the percent s&o& were 
be adv,!n;ed, the leGon was predilated with a 2- or 2.5.mm determined. 
balloon before insertion of the catheter. If significant steno- In addition to quantitative analysis, cineangiograms were 
sis remained after the atherectomy attempts, ths leGon was reviewed for eccentricity, presence of calcification, ostial 
subsequently dilated with a standard balloon to achieve an involvement, contour of the lesion (ulceration, flap, diasec- 
adequate resutt. don), aogulation at the lesion, tortuosity of the vessel, 
The patient received premedica!ion with aseirin (80 to branch involvement, thromhus and anterogade Row as 
r2S mg/day orally) and a calcium channel blocker. During defined in the Thmmbolysis in Myocardial Infarction (TIMI) 
the procedure. a boius dose of he&n (IO,Mx) U) was trial (16). In addition to quantitative measurements, postpro- 
administered intravenously, followed by 3,ClN U/h. After the cedure cineangiograms were reviewed for the presence of 
procedure, in most cases the patient received no additional dissections. Dissections included maior dissections. defined 
or only a maintenance dose of heparin for < I2 h. The patient as dissections with staining of the &rest material in the 
was maintained on thcrap] with aspirin indefinitely and a vessel walls; minor dissections, defined as dissections with- 
calcium channel blocker for 2 to 3 weeks. out contrast staining and intimal flaps, defined as intmlumi- 
Patient inclusion and follow-up protocol. Between Octo- oat linear defects. 
ber i986 and December 1989. 393 lesions in 342 patients Data anPly& and definition. All clinical and angiographic 
were treated for the first time with directional coronary information was audited and stored in a computerized data 
atherectomy. Of these, 332 lesions were successfully treated bank (Medlog System, Advanced Information An&&CoQ.). 
(85% success rate). The 289 patients who had successful Only follow-up information obtained at ~90 days was 
directional coronary atherectomy were included in this used for analysis unless the patient reached an end point, 
study. such as angiographically documented restenosis, death or 
These 289 patients were followed up prospectively. tn- subsequent intervention. If the patient had more than one 
formation on symptomatic status (Canadian Cardiovascular follow-up evaluation, the latest follow-up information was 
Soci. y functional class) was obtained at approximately 6 
months by a mailed qttestionnzire or telephone communica- 
used for analysis. 
Angiographic evidence of restenosis was defined as 
tion. This information was obmined at the time of any X0% stenosis at the atherectomy-treated segment of the 
rubsequent event (surgical or interventional procedure or vessel. The overall restenosis rate and the restenosis rate in 
myocardial infarction) that occurred before 6 months. All each group categorized by the nature of the vessel (native or 
patients were asked :o undergo repeat cardiac catheteriza- vein graft) and lesion type (primary or restenosed lesion) 
tion at approximately 6 months, or earlier if symptoms were obtained. Results were compared by using chi-square 
recurred. Coronary angiograms wae performed by standard analysis. Quantitative measurements of the angiograma in 
technique. each category were expressed as mean value f SD. Changes 
Arabsis of coronary angiogrsms. Coronary angiograms in the mean values in each group were compared by using .^ 
were obtained I” m”tI.,pte pro,ect,ons betore rdherectomy; pared 1 tests. In addtttott, quantitattve tneasorements among 
groups (primary vs. restenosis lesions1 were compared by 
using unpaired t tests. Probability (PI values were expressed 
with Bonferroni 8djwment hecarrsc of mrdti?le compali- 
sons. 
Factors related to restenosis were separately analyzed m 
lesions in native coronary arteries and in saphenow vein 
grafts. The factors examined were I) clinical factors (age. 
gender. diagnosis. functional class. previous angioplastyl 
and coronary risk factors (smoking. diabetes. hypercholes- 
teralemia, hypertension and family history): 2) preatherec- 
tomy angiographic factors (vessel diameter 2 or ~3 mm, 
lesion length < or 210 mm. eccentricity. calcification. 
contour, an&&n and ostial involvement); 3) procedural 
factors (predilation brlure atherectomy attempts. device 
size. use of higher pressure I>30 psil. postatherectomy 
lesion diameter [a or <3 mm1 and overdilation I< - 10% 
stenosis]); and 4) pastathereclomy dissection/flap. Chi- 
square analysis was used to determine the relation between 
the factors and the frequency of reslenosis. 
Palint and lwiin charaeteristicr. Patient characteristics 
of the 289 plienls who were eligible for follow-up are 
summarized in Table 1. Thirty-six percent of the patients had 
a history of unstable angina. defined as new onset, progres- 
sive or prolonged angina, and 33% of Patients had rest 
angina. Characteristics of 332 lesions eligible for follow-up 
are summarized in Table 2. Eighty-one percent of the lesions 
were located in na!lve ccvxwy xteries ?nd !% were !n 
saphenous vein arafts. More than 50% of the lesions were 
pr&usly U&d with angioplasty and 30% were treared 
with two or man! prior angioplasty procedures. Thiny 
percent of lesions were predilated with use of a balloon 
catheter before atherectomy was attempted. The mean post- 
atherectomy residual stenosis was I I .6 t 19.2% and 71% of 
lesions had a residual stenosis of ~20%. An overdilated 
appearance (i - 10% residual stenosis) was observed in 10% 
of lesions. 
Clinical outcome. Clinical follow-up data at approxi- 
mately 6 months after athereetomy, or earlier if symPwmo 
recurred, were abtained in 98% of patients: however, five 
patients (2%) were lost to follow-up evaluation. At follow- 
up. Sl% were in Canadian Cardiovascular Society angina 
class 1.21% were in class II, 17% were in class 111 and 10% 
were in class IV. Seventy-four percent of patients were 
either a<ymptomatic or had an improved clinical status. 
Fourteen percent of patients had angina similar to that 
before atherectomy and I I% had angina that was worse than 
that before atherectomy. One hundred eleven patients 
(38.4%) had restenosis documented by angiagraphy. For 
these patients with wstenosis, 1% were in angina class I, 
26% were in class 2, ?I% were in class 3 and 24% were in 
class 4. Of these. 86 patien‘s were subsequeurly treated: 3% 
with angioplasty, 13% with repeat atherectomy and 14% 
with coronary atwy bypass graft surgery. Of those 41 
Pw~ent Stenosis at Follow-up Figure !. Dtstribulion of quantitatively meawed per- 
cent stenosis of the atherectomy-treated segment at 
followup angiography. Top, Native coronary arteries. 
I Rimaly Lesion 
Bo,,om, Saphenous “em grafts. 
0 ReS,~“05~d L&D” 
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patients who did not have angiographic evaluation. 12% had 
recurrent angina and 10% (3 of 30 patients) had a positive 
exercise test~rcsult. 
Angiographic fottaw-up. Angiographic evaluation was 
performed for 280 lesions with .a mean follow-up interval of 
170 days (range 41 to 405) and a compliance fate of 82.4%. 
The distribution ofstettoses at follow-up of the atherectomy- 
treated segment is summarized in Figure 1. The severity of 
the stenosis was evenly distk i iuted. Total occlusion (Thram- 
bolysis in Myocardia~lnfarcGm trial [TIMI] grade 0 or 1) 
Rgure 3. Rertenmis rates after directional coronary 
2!hsrectomy of wsrall, primary and rsxtenosed lesions in 
native carona_i zteries xd sapherovs win qrafts (native 
artery vs. sapbenous Yein graft, p < 0.001; pnmary or one 
previous angioplasty [PTCAI vs. two or more previous 
angioplaaly procedures, p = 0.01 far native arteries. p = 
0.0 for saphenous win gralts). 
and :U 2% 110 lesions) of saehenous vein grafts. 
Ths time to anaiwravbic restcnws is illustrated in Fieure 
2 Ang!ograph&ly do&tented restenosis ~8s obrervc> at 
a median intewal of 133 days (1st quartile 93 dayr. 3rd 
quartlle IX7 days). The median interiai was 140 days (trt 
quartdc IW days, 3rd quartile 190 days) for lesions in native 
coronary arteries and I20 days (lit quartile 76 days, 3rd 
quartile 163 days) for lesions in sa?henous vein grafts (p = 
0.08 “Jilcoxon rank-sum test). 
The severity of stenosis (exprwed r.3 percent stenor~s) 
and abwlute lesion diameter (mm) b.:fore atherectomy. after 
atherectomy and at follow-up are summarized in Table 3. In 
nniiw coronary arteries. stenoses measured at follow-up 
(hs.th percenr stenosis and absolute diamcwr) were more 
significant than those measured immediz:cly zf:zr athercc- 
tomy but remained less significant than those measured 
before atherectomv. In native comnarv arteries. stenows at 
follow-up were I.& sigmficant in pri’mary l&s than in 
restenosed lesions 137% vs. 45.1% anosis. D < 0.05: 2.05 
vs. 1.72-am tesion~diamcter, p < 0.05) eve; though ‘there 
was no di5erence in residual stenases immediatuy efter 
a!herec:cmy (12.6% vs. 9.9S stenosis, p = NE: 2.59 vs. 
2.9.mm lewn diameter. p = NS). In saphenous vein grafts, 
stenow at follow-up were more significant than thaw 
mewrcd rmmcdiately after the procedure. Allhough the 
stcnoscs at follow-up were less significant than were preath- 
erectomy stermses in the overal! grwp of saphen& vein 
gr&, there were no significant di5erences between preatb- 
erectomy and follow-up stenoses. in the subgroup of primary 
or restenored lesions. Stenoses at follow-up were similar 
fp L NSI Letueen primary and restenosed lesions. 
Rzstensk 2t(c. Restenasis rates defined as SO% of the 
athercctomy-treated segments arc summarized in Figure 3. 
The overall restenosis rate was 42%. Rcstenosis was signif- 
icantly less frequent in native coronary arteries than in 
saphcnous vein grafts (37% vs. 63%. p < 0.031). Among 
native coronary arleries, restenosis rates were similar (30%) 
for primary lesions and lesions previously treated only once 
by angioplasty; however. they were significantly higher 
(47%. p = 0.01) for lesions previously treated two or more 
times wth angioplasty. Similar results were observed for 
saphenous rein grafts. The reslenosis rate was 55% for 
primary lesions or lesions treated with only one previous 
angioplasty and 82% for lesions treated two or more times 
with angioplasly Cp = 0.09). 
Table 5. Factxs Associated With Restenosis 
Vessel Categary Factors 
35% Ku, 
,p = “.“x!, ,p = 0.031 ,p - 0.42, 
summarized in Table 4. There was no statistically significant 
difference in restemxis rates among native coronary arteries 
or among lesion locations. 
Predictors al rertenosis. The clinical, angiographic and 
procedural factors related to restenosis after directionat 
coronary atherectomy are summarized in Table 5. Clinical 
factors associated with higher restenosis rates were history 
of hypertension in the overall group and hypertension, older 
age and class IV angina in the native anery group. Math- 
erectomy angiog?sphic factors associated with higher rates 
were longer lesion, smaller vessel diameter, noncalcified 
lesion for the overall group and longer lesion and smaller 
vessel for the native artery group. Procedural factors related 
to restenosis were use of a smaller (GF) device for the 
overall group and native artery group and use of a small 
device and postatherectomy diameter of <3 mm in the native 
artery primary lesion group. Restenosis rates related to each 
factor in native coronary arteries and saphenous vein grafts 
are summarized in Tables 6 and 7 and Fkure 4. Rwenosis of 
primary lesions in native arteries occurred in 24% of vessels 
23 mm, 15% ofthose with 23.mm diameter after directional 
coronary atherecfomy and 12% when a 7F device was used. 
Table 1. Saphenous Vem Graft Angiographic and Procedural 
Pactors and RCste”OSis Rate 
The relation between resterto& and the time from previ- 
ous angioplasty to directional coronary atherectomy is 
shown in Waure 5. The restenosis rate for those lesions with 
a shorter duration (<I20 days) after previous angioplasty 
was significantly higher than for those with a longer duration 
(=12Odays): 55.8% vs. 18.8%, p < O.Wl. 
Diis.sion 
This is the first study to examine restenosis after success- 
ful directional coronary atherectomy in a relatively large 
number of patients. Although one of the goals of directional 
coronary atherectomy is to reduce restettosis by dehulking, 
our results suggest that restenosis after this intervention 
con!inues to bc a stgniticam problem. The mstenosis rate in 
our study was 37% for native crteries (31% for primary 
Figwc 4. Rcstcnosis rates of primary lesions in narive coronary 
arteries in relation to angiogiaphic or procedural factors. Post = 
after athereetomy. 
lesions) and 63% for xtpi~ettous vein grafts (34% for primary 
lesions). .4lthough the over’ail incidence of rcstcnosis was 
not dramatically rcduscd compared with *hat after coronary 
angioplasty. the long-term outconx after directional cow 
nary atherectomy appeared to be more favorable for short 
lesions. lesions in relatively large vessels and lesions treatcd 
with a large device. Clearly, tiuther studies are necessary to 
evaluate the incidence ofrestenosis compared with that after 
angioplasty. 
Directional coronary stbcrectwny. Atherectomy was in- 
troduced to overcome some of the limitations of pcrcotane- 
ous transluminrd coronary angioplasty, mainly primary fail- 
ure due to elastic recoil, dissections or acute wclosion and 
restenosis (14). Directional coronary atherectomy was de- 
signed to safely remove part of the obstrttctive tissue in the 
vessel. using a transluminal catheter to improve blood Raw 
through the obstrwtion rather than simply dilating the lesion 
with a balloon. Currently, the directional coronary atherec- 
tomy device is the only new interventionat device approved 
by the Food and Drag Administration for general clink! 
use. The initial experience in a mol!iccn:er trial (16.22,23) as 
well as oar Sequoia Hospital experiencs demonstrated the 
safety and efficacy of this new procedure. The overall 
success rate was approximately SW& with an approximately 
3% rate of complications requiring bypass surgery. Dircc- 
tional coronary atberectomy teems to be particularly effec- 
tive for the trcatmcnt of eccentric lesions, lesions with an 
abnormal morphology, left anterior descending ostial le- 
sions, tubular lesions and selected aorto-ostial lesions 
(16,24,2.5). In cornmst, it has a low success rate and a high 
complication rate, in patients with calcification or diffusely 
diserxsed vessels. Although there has been no randomized 
triai to compare the immediate efficacy of directional corn- 
nary .dhcrectomy and aogiopiariy, iLowe et al. (26) demon- 
strated a more favorable angiographrc outcome after direc. 
tional coronary atherectomy than after angioplasty in a 
retrospective analysis of a matched group. The residual 
stenosis was significantly lower after atherectomy with a 
much smalkr incidence ofdissection or rntimal Rap, suggest- 
mg that removal of the obstructive ticwc creates a larger and 
smoother lumen. 
Mechanisms of resten& and goal nf new fechnique. One 
major limitation of percutaneous tnnFluminal coronary an- 
gioplasty is restenosis, which occurs in approximately 35% 
to 50% of lesions after successful angioplasty (S-8). Animal 
models, human autopsy studies and our examination of 
excised tissue from atherectsmy procedures demonstrate 
that the major cause of restermsis is smooth muscle cell 
proliferation at the site of intervention. In addition, elastic 
recoil due to mechanical forces may play some role in the 
development of restenosis. Pathologic studies (13) from 
autopsy specimens suggest that in some Casey elastic recoil 
is the major reason for restenosis without significant intimal 
hyperplasia. It is likely that many cases of restenosis are a 
combination of predominant intimal hyperplasia with 
smooth muscle cell proliferation and some component of 
elastic recoil. The goal of many new interventional tech- 
niques, including atherectomy. is to decrease the incidence 
of rester&s as well as to improve the immediate outcome, 
Although the mechanisms of these various new interven- 
tionai techniques differ, they are similarly intended to reduce 
restenosis by I) creating a larger lumen. 2) creating a 
smoother surface, or 3) preventing elastic recoil. The prolif. 
err&n of smooth muscle cells and matrix formation at the 
interventional site may be self-limited and may cease sport- 
taneously with time. Creation of a larger intraluminai diam- 
eter by new interventional techniques such as atherectomy 
or stents may provide more space in the vessel for prolifer- 
ative Iissue, thereby allowing partial restenosis to occur 
without creation of a hemodynamically significant stenosis. 
Preliminary data from the stem experience (27) suggest hat 
the restenosis rate in larger vessels i  lower than that in sinail 
vessels !E addiiion, new interventional tecbniaues rnw 
create a smoother surface on the treated segrne~t, which 
may cawe less turbulent blood Row. The more favorable 
Row pattern may prevent or reduce the amount of ihrombus 
formation or platelet aggregation that can cause cell prolif- 
eration. Lastly, new interventional techniques may prevent 
elastic recoil by mechanical stating or removing lissue from 
the obstruction. 
Restenosis after directIonal coronary atherectomy. The 
overall restenosis rate of 42% after dimctional coronary 
atherectomy in our study is similar to the reported restenosis 
rate after angioplasty; however, the patients in this study 
are different from typical patients undergoing angioplasty. 
Many were referred to our institution because of high risk 
complex morphology. Furthermore, many lesions were 
treated by multiple previous angioplasry procedures and 
patients underwent directional coronary atherectomy be. 
cause of refractory recurrent restenosis. In addition, the 
number of graft lesions was relatively large in our expai- 
ence. The restenosis rate of primary lesions or lesions 
previously treated with only one angiopiarty procedure in 
native coronary arteries was approximately 30%. This rate is 
not dramatically lower than the restencris rate after angio- 
pras!y. !! is obvious that randomized studies are necessary to 
c?aluate the difference in the incidence of restenosis after 
the two procedures. 
Although the atherectomy procedure is different from 
angioplasty, the timing of the reqtenosis after the procedure 
is similar to that after angioplasty. Peak restenosis occurred 
within approximately 3 months after atherectomy and in 
Y9O% of&es it occurred within 8 months. In this report, 
the cause ofrestenosis after atherectomy was not addressed: 
however, our preliminary results (28) in patients who under- 
went a second atherwomy procedure after restenosis sug- 
gest that most patients had significant smooth muscle cell 
proliferation. These data suggest that cell proliferation after 
directional coronary athcrectomy remains a significant cauw 
of restenosis. 
Risk factors for restenosls after stherectomy. Same of the 
risk factors associated with restenosis after directional car- 
onaty atherectomy include lesions in a saphenous vein graft, 
lesion length, use of a mall device, smaller vessel, noncal- 
cified lesion, small pastatherectomy lumen diameter, class 
IV angina, hypertension. age, number of previous r&o- 
plasty procedures and short interval after prwious a&o. 
&sty. One important faclor in restenosis is the number of 
interventions performed before directional coronary 
atherectomy. Owexperience sugqests that patients with Iwo 
or more previous angioplasty prnccdures had a higher inci- 
dence of restenosis after directiomd coronary atherectomy; 
however. lesions with only one previous angioplasty did not 
demonstrate significantly different rcstenasis rates from 
those of primary lesions. This trend was observed in bath 
native coronary arteries and saphenous vein gafts. In addi- 
tion, the time from previous angioplasty to directional cor- 
onary atherectomy was found to influence the incidence of 
restenosis; shorter duration (<I20 days from previous an- 
gioplasty) was associated with a higher incidence of reste- 
nosis than that in the late restenasis group. For those whose 
angioplasty was performed 1120 days before directional 
coronary atherectomy, the restenosis rate was similartothar 
in primary lesions. Those patients with aggressive restenosis 
after angioplasty (such as recurrent stenosis or short interval 
from previous angioplasty) had  biih incidence ofrestenosis 
even after directional coronary atherectomy. These data 
Suggest hat our results for the total study group may be 
somewhat skewed from those observed in typical patients 
undergoing angioplasty because of the inclusion of many 
patienls with aggressive restenosis. 
Lumen size and resteoasis. Some results from the sub. 
group analysis suggested the importance of a large lomen. 
The restenosis rate seems to be relatively low for large 
vessels (23 mm). lesions treated with a 7F device (oat a 5 or 
6F device) and vessels with a large postprocedure diameter 
(a3 mm). The restenosis rate for pnmary lesions was 24% 
for vessels 23 mm. 12% for those treated with a 7F dewce 
and 15% for vessels with a poststenosis diameter r3 mm. 
These results suggest hat directional coronary atherectomy 
may be more effective in reducing restenosis in large vessels 
by L&Y, d rclativcly Ihrge devicr and acluewg a waer 
postintetventional lumen. These results support the concept 
that a large lumen aI!ows “tore tissue to grow without 
creating a hemodynamically significant stenosis. Although 
low rates afrestenosis in these subgroups are encouraging, it
is premature to conclude that atherectomy reduces resteno- 
sis in these selected subgroups because of the relatively 
small n&rkerr of lesions studied. 
Limitatlollr of the study. Because this was an okserva- 
tio”aI study and not a randomized study to compare re- 
stenosis rates after directional coronary atherectomy and 
angioplasty, it is premature to compare our results directly 
with those after aogioplasty. The patients in this study may 
d&r significantly from typical patients undergoing aogio- 
plasty. It is obvious that a mttdomized study is necessary to 
compare the restenosis rates after the two procedures. 
In this study, most patients ““detwe”t follow-op angiog- 
raphy at approximately 6 months if they were relarively 
asymptomatic. Although mu:, restenosw occurred after a” 
interval simile to that seen Mb angioplasty. it ir important 
to obtain longer follow-up information because vessels with 
pzo?ia! restsnosis (for :xample. 30% to 40%) at 6 months may 
show lesion progression with time. Subsequent studies are 
necessary 1o determine whether Ibe rate of late restenosis is 
as infrequent as that see” in angioplasty. 
Altholgk directional coronary atherectamy is currently 
approved by the Food and Drug Administration, it is still a” 
evolving technique. The optinal c?se sciectbn sod methods 
for perfotming atbeiectomy are unknown. Factors that need 
to be determined include the influence of procedutal tech- 
nipues such as the size of the device compared with the 
v&i size, peak pressures used, amount of &sue removed 
and the oplimal angiogmphic appearance after directional 
coronary atherectomy. We hai; continued to adjust our 
technique over the last few years. Garrett et al. (21) suggest 
that adeep cutfexcision ofmedia oradventitia) incrr :he 
incidence of reslenosis. I” our study. the relation bstwee” 
the histologic haracteristics ofexcised tissue and restenosis 
was “at examined; however, a lower reatenosis rate in 
vessels with a large pestatherectamy diameter and “se of a 
larger device suggest that the long-term outcome may be 
more favorable with removal of more tissue. Further study 
examining the relation among an&graphic findings, hir- 
tologic findings and restenosis rates will help to optimize the 
atherectomy procedure. 
In addition to changes in the technique used for athew. 
tomy, the device used for the procedure continues to evolve. 
Newer devices are now available as iwesrigational tools and 
may influence the incidence of restenosis with a less trao- 
maw approach to the letion and more elTective atherectomy 
than are pacsible with the current device. Although we do 
not expect to see a dramaic rhwge in the rertenosis rate. 
:hesc changes in the procedure and the device may have 
soox nnpact on the incidence of restenosis. Thus. it is 
ilrportant to conduct further studie; when the atherectomy 
prowtore becomes more standardized. 
Conclosionr. This study demonstrates that restenosis 
contmues to be a limitation of directional coronary atherec- 
tomy. Overall, the restenosis rate seems lo be similar to that 
after angioplxty. This pmcedure may be more effec*ive in 
reducing restenosis in selected cases (short lesmns. large 
vessels and lesions that can be treated with a 7F device). In 
addition. it may be important to achieve an optimal lumen 
diamerer after directional coronary atherectomy to reduce 
restenosis. Currently. a rando”wed ttial (Coronary Angio- 
plasty Venus Excisimal Atherectomy Trial) comparing 
angioplasty and directional coronary atherectomy is under- 
way to answer some of these questions. 
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